Risk factors for renal toxicity after inpatient cisplatin administration

BACKGROUND: After several decades, cisplatin continues to be an essential drug for the treatment of several tumors, however, its potential nephrotoxicity is still a clinically relevant issue. Identification of predisposing factors for renal toxicity could be of value to warrant prophylactic measures...

Descripción completa

Detalles Bibliográficos
Autores principales: Galfetti, Elena, Cerutti, Alessandra, Ghielmini, Michele, Zucca, Emanuele, Wannesson, Luciano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052961/
https://www.ncbi.nlm.nih.gov/pubmed/32122396
http://dx.doi.org/10.1186/s40360-020-0398-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052961/
https://www.ncbi.nlm.nih.gov/pubmed/32122396
http://dx.doi.org/10.1186/s40360-020-0398-3

Ejemplares similares